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Egle Corrado, MD, Emiliano Navarra, MD, Davide Calvaruso, MD, and Giovanni Ruvolo, MD
Objective: Surgical management of moderate chronic ischemic mitral valve regurgitation is still debated. The
aim of this study was to evaluate the effect of adding mitral valve repair to coronary artery bypass grafting on
clinical outcomes and left ventricular remodeling in patients who underwent coronary artery bypass grafting alone
versus coronary artery bypass grafting plus mitral valve repair in a randomized trial.
Methods: Between February 2003 and May 2007, 102 patients were eligible for this study and were randomly
assigned to one of 2 groups by means of card allocation: coronary artery bypass grafting plus mitral valve repair
(CABG plus MVR group; 48 patients, 47%) or coronary artery bypass grafting alone (CABG group; 54 patients,
53%). The 2 groups were similar regarding demographics, perioperative clinical data, and outcomes. There were
differences regarding cardiopulmonary bypass (P< .0001) and aortic crossclamp (P< .0001) times. Exercise
tests were performed for all survivors to evaluate tolerance to exercise and variability on grade of mitral regur-
gitation and systolic pulmonary arterial pressure. The study was blinded for physicians and nurses involved in
postoperative care and clinical follow-up. The mean follow-up was 32  18 months.
Results: Overall in-hospital mortality was 3% (3 patients). One (1.8%) patient died in the CABG group, and 2
(4.1%) patients died in the CABG plus MVR group. Survival rates  standard error at 5 years for patients in the
CABG and CABG plus MVR groups were 88.8%  3.2% and 93.7%  3.1%, respectively. A significant dif-
ference was found between the 2 groups with regard to mean New York Heart Association class (P<.0001), left
ventricular end-diastolic diameter (P< .01), left ventricular end-systolic diameter (P< .01), pulmonary arterial
pressure (P<.0001), and left atrial size (P<.01). At follow-up, coronary artery bypass grafting alone was able to
reduce mitral regurgitation grade in 40% of patients, whereas in the remaining patients mitral regurgitation grade
remained stable or worsened. In the CABG group, among the 17 patients with mild mitral regurgitation and 12
patients with moderate mitral regurgitation at rest, 7 (40%) and 9 (75%) patients, respectively, had worsening in
mitral regurgitation grade and pulmonary artery pressure during exercise.
Conclusions: The efficacy of adding mitral valve repair to coronary artery bypass grafting is well demonstrated
by the improvement of New York Heart Association functional class and percentage of left ventricular ejection
fraction and by the decrease of mitral regurgitation grade, left ventricular end-diastolic diameter, left ventricular
end-systolic diameter, pulmonary artery pressure, and left atrial size. Moreover, coronary artery bypass grafting
alone left more patients with heart failure symptoms at rest and during exercise. Combined coronary artery bypass
grafting and mitral valve repair have no effect on survival at short-term follow-up, and the trends that are evident
will likely become more significant with time.Chronic ischemic mitral regurgitation (cIMR) is a functional
mitral regurgitation (MR) characterized by a normal leaflet
structure and subvalvular apparatus and mostly related to
an inferior rather than an anteroseptal myocardial infarc-
tion.1 According to type IIIb Carpentier’s functional classi-
fication, ischemic mitral regurgitation (IMR) is the
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Leaflet tethering displaces the mitral coaptation rim toward
the apex of the left ventricle, causing an incomplete closure
of the valve in systole.2,3
In the natural history of patients after myocardial infarc-
tion, the presence and degree of cIMR are independent
risk factors for mortality.4,5 Moreover, cIMR in patients
with coronary disease is associated with an excess of mortal-
ity independently of baseline characteristics and degree of
ventricular dysfunction, but the highmortality rate is directly
related to the grade of IMR evaluated based on the effective
regurgitant orifice area at echocardiographic analysis.6
Today there is general agreement that moderate-to-severe
to severe (grade 3þto 4þ) cIMR should to be corrected at the
time of coronary artery bypass grafting (CABG),7-9 whereas
trace-to-mild (grade 1þ) cIMR does not require any surgicalrgery c August 2009
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CABG ¼ coronary artery bypass grafting
cIMR ¼ chronic ischemic mitral regurgitation
CPB ¼ cardiopulmonary bypass
IMR ¼ ischemic mitral regurgitation
LVEDD ¼ left ventricular end-diastolic diameter
LVEF ¼ left ventricular ejection fraction
LVESD ¼ left ventricular end-systolic diameter
MR ¼ mitral regurgitation
MVR ¼ mitral valve repair
NYHA ¼ New York Heart Association
PAP ¼ pulmonary artery pressure
TEE ¼ transesophageal echocardiography
TTE ¼ transthoracic echocardiography
treatment. On the other hand, the optimal management of
moderate (grade 2þ) cIMR is still controversial.10-20
Authors advocating mitral valve repair (MVR) at the time
of CABG suggest that CABG alone will not correct moder-
ate cIMR in many patients with scarring caused by myocar-
dial infarction and those with annular and ventricular
dilatation11,21; moreover, significant residual MR after
CABG can worsen the prognosis of patients, resulting in
late symptoms and decreased long-term survival.5,11,22 Mi-
tral annuloplasty is nearly always feasible, and it alone
will correct moderate cIMR with an operative mortality
rate as low as 3% to 4%.11,23,24 Finally, cIMR is a dynamic
condition that is dependent on preload and afterload and can
vary in grade with exercise.25,26
On the other hand, authors favoring a conservative ap-
proach believe that revascularizing ischemic myocardial
areas will improve regional wall motion and correct
cIMR,12 that residual MR after CABG alone does not affect
long-term survival or functional status,10,13 that the com-
bined approach is associated with high operative mortality
rates,27,28 and that patients with cIMR tend to have a small
left atrium, which makes MVR a demanding procedure.
In this study we aimed to evaluate prospectively the early
and midterm results of patients with moderate (grade 2þ)
cIMR who underwent CABG or CABG plus MVR in a ran-
domized trial.
MATERIALS AND METHODS
Patients
Between February 2003 and May 2007, 132 patients with coronary ar-
tery disease and moderate cIMR admitted to our department for CABG
were consecutively and prospectively screened for this study. All patients
had moderate cIMR caused by restrictive systolic leaflet motion (Carpent-
ier’s type IIIb), annular dilation (Carpentier’s type I), or both. Patients
with a recent myocardial infarction (<30 days), unstable hemodynamic sta-
tus requiring urgent surgical intervention, concomitant aortic valve opera-
tions, organic mitral valve lesions requiring MVR, and requirement for
surgical left ventricular restoration were excluded from the study. Finally,The Journal of Thoracic and102 patients were eligible for the study and randomly assigned to one of
2 groups: CABG plusMVR (48 patients, 47%) or CABG alone (54 patients,
52%). Patients were randomized by means of card allocation. Randomiza-
tion was blinded for intensive care unit and postoperative care staff, includ-
ing nurses, anesthetists, and cardiologists. This study was also blinded for
the cardiologists who performed the clinical follow-up.
The grade ofMRwas evaluated by using transthoracic echocardiography
(TTE) at resting conditions preoperatively and by using transesophageal
echocardiography (TEE) intraoperatively. The mean EuroSCOREs were
6.5  5.1 and 6.1  4.8 for the CABG and CABG plus MVR groups,
respectively. Baseline characteristics of the population are presented in
Table 1. Each patient signed an informed consent form. The study was
approved by the institutional review board of our university.
Clinical Study End Points
The primary end points of the study were to evaluate the effect of adding
MVR to CABG on the clinical status of patients measured based on
NewYork Heart Association (NYHA) functional class and on postoperative
reversal of left ventricular remodeling measured based on left ventricular
end-systolic diameter (LVESD), left ventricular end-diastolic diameter
(LVEDD), and left ventricular ejection fraction (LVEF).
The secondary end point of the study was to assess the tolerability to ex-
ercise of all patients in the repair group and of patients in the CABG group
with postoperative residual MR of grade 2þor less and to evaluate the var-
iability of the MR grade during exercise and its effect on dyspnea and sys-
tolic pulmonary artery pressure (PAP).
Moreover, the effect of adding MVR to CABG on early and late mortal-
ity and postoperative outcomes was also evaluated.
Surgical Technique
All surgical procedures were performed through a longitudinal median
sternotomy during normothermic cardiopulmonary bypass (CPB) with in-
termittent antegrade warm blood cardioplegia. All patients underwent con-
ventional multivessel CABG with the use of left internal thoracic artery and
saphenous vein grafts. All distal anastomoses were performed during a sin-
gle aortic crossclamping. The proximal graft anastomoses to the aorta were
performed with partial crossclamping of the ascending aorta. After weaning
from CPB, the mean graft flow was assessed by mean of Doppler transit-
time flowmetry for each graft by using a flowmeter (Transonic Systems,
Inc, Ithaca, NY). Postoperative intensive care unit management was stan-
dardized for all patients.
Mitral valve annuloplasty was performed with a Carpentier–Edwards
Physio Ring (Edwards Lifesciences, Irving, Calif). The size of the ring
was determined after careful measurement of the height of the anterior
leaflet. We measured the height of the A2 segment by means of TEE (trans-
esophageal view at 120), and we chose a prosthetic ring with an anteropos-
terior diameter of less than 0.8 to 1 cm with respect to the height of the A2
segment. In this manner we ensured at least 0.8 cm of the free margin of the
anterior leaflet into the surface of coaptation. Rings were inserted by using
deep horizontal U sutures with Ti-Cron 2-0 (Syneture, Norwalk, Conn).
Surgical data are summarized in Table 2. All patients had intraoperative
TEE assessment of the left ventricle and valve function after repair. MVR
was considered successful if there was no or trivial residual MR postoper-
atively. Mean leaflet coaptation height was 8  3 mm.
Echocardiographic Definition of MR
Echocardiographic imaging was performed by using standard transtho-
racic windows with a Hewlett–Packard Sonos 5500 imaging system (Palo
Alto, Calif) equipped with a 2.5-MHz transducer. All echocardiographic
studies were performed and interpreted by 2 experienced cardiologists.
Mitral valve regurgitation was defined as functional IMR when associated
with global or regional left ventricular systolic dysfunctionwith no evidence
of primary leaflet, chordal, or papillary muscle pathology. End-systolic andCardiovascular Surgery c Volume 138, Number 2 279
Point/Counterpoint Fattouch et alend-diastolic diameter and volume of the left ventricle and ejection fraction
were measured and calculated. Global and regional wall motion abnormal-
ities were evaluated with a 16-segment model. By using the simplified
proximal isovelocity surface area method, the degree of MR was graded
as moderate (2þ) when the radius of the proximal isovelocity surface
area was between 5 and 8 mm. The severity of MR was also evaluated
by using the quantitative Doppler method with mitral and aortic stroke
volumes.
Clinical and Echocardiographic Follow-up
All patients were followed up at our outpatient clinic by our cardiolo-
gists. Clinical and TTE controls were performed by the same cardiologists
who evaluated the population study preoperatively. The physician who per-
formed the clinical follow-up was blinded to study design. Preoperative and
postoperative clinical status was determined according to the criteria of
NYHA functional class and the Canadian Cardiovascular Society for heart
failure and angina, respectively. Follow-up data were obtained in all survi-
vors at 1, 3, and 5 years. Follow-up ended December 30, 2007, and was
100% complete. The mean follow-up was 32  18 months (range, 6–60
months).
Treadmill stress tests and, at the same time, TTE controls were per-
formed at the last follow-up to evaluate clinical status under exercise condi-
tions (evaluated based on appearance of dyspnea, fatigue, and/or angina)
and the variability of the grade of MR and systolic PAP. As soon as the
treadmill test was interrupted, an echocardiographic examination was per-
formed with the patient in the semisupine position. b-Blockers were stopped
24 hours before testing. A symptom-limited grade was evaluated. After an
initial workload of 25 W had been maintained for 6 minutes, the workload
TABLE 1. Preoperative patient’s characteristics
Variables
CABG group
(n ¼ 54)
CABGþMVR
group (n ¼ 48)
P
value
Age (y) 66  7 64  9 .62
Age>75 y 9 (16.5%) 7 (14.5%) .56
Sex (male) 35 (64.8%) 30 (62.5%) .42
Diabetes 32 (59%) 28 (58.3%) .78
COPD 5 (9%) 4 (8.3%) .73
Hypertension 23 (42.5%) 26 (54%) .07
Previous MI
Anterior 7 (13%) 5 (10.5%) 0.51
Inferior-post-lateral 44 (81.5%) 40 (83%) 0.79
Both 3 (5.5%) 3 (6.2%) .68
Mean NYHA class 2.4  1.5 2.3  1.1 .56
Two-vessel disease 15 (27.7%) 13 (27%) .91
Three-vessel disease 39 (72%) 35 (73%) .87
Serum creatinine>1.5 6 (11%) 5 (10.5%) .82
Logistic EuroSCORE 6.5  5.1 6.1  4.8 .54
LVEF (%) 43  9 42  10 .71
LVEF<35% 8 (15%) 6 (12.5%) .55
LVEDD (mm) 58  7 59  8 .67
LVESD (mm) 44  7 45  8 .61
sPAP (mm Hg) 42  11 40  10 .53
Left atrial
diameter (mm)
38  7 39  8 .68
Tenting area (cm2) 1.7  0.7 1.8  0.6 .71
Data are presented as means  standard deviation or number (percentage) as shown.
CABG, Coronary artery bypass grafting; MVR, mitral valve repair; COPD, chronic
obstructive pulmonary disease; MI, myocardial infarction; NYHA, New York Heart
Association; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-
diastolic dimension; LVESD, left ventricular end-systolic dimension; sPAP, systolic
pulmonary arterial pressure.280 The Journal of Thoracic and Cardiovascular Suwas increased every 3 minutes by 25 W. Blood pressure and a 12-lead elec-
trocardiogram were recorded every 3 minutes. Bidimensional and Doppler
echocardiographic recordings were available throughout the test. Exercise
was interrupted when ischemic electrocardiographic signs, fatigue, or intol-
erable dyspnea appeared.
Statistical Analysis
Numeric values were expressed as means  standard deviation. Contin-
uous variables were compared between 2 groups by using Student’s un-
paired t test. The frequency ratios between 2 groups were compared with
the c2 test. Left ventricular remodeling data were analyzed with the paired
t test and the Wilcoxon signed-rank test. Interval-scaled variables, such as
age and CPB and aortic crossclamp times, were analyzed by using simple
univariate linear regression tests. Actuarial survival and other time-related
events were analyzed with the Kaplan–Meier method. The log-rank test
was used to compare the statistical significance level.
To calculate the sample size in our study to achieve a power of 90%
(with a difference of 5%), we used postoperative reversal of remodeling as-
sessed mainly based on LVESD reduction from preoperative to follow-up
value. We used LVESD reduction because we believe that it better corre-
lates with postoperative reversal of left ventricular remodeling. In fact,
the reduction in LVEDD is not necessary correlated with a reversal of re-
modeling and improvement in left ventricular function. In case of LVEDD
reduction during follow-up, if LVESD remains unchanged or increases,
LVEF decreases. On the other hand, if LVESD decreases, LVEF might
be unchanged in the case of contemporary LVEDD reduction or even im-
prove if LVEDD remains unchanged. Thus, we believe LVESD is a good
tool to assess left ventricular remodeling.
TABLE 2. Intraoperative and postoperative patient’s data
Variables
CABG group
(n ¼ 54)
CABGþMVR
group (n ¼ 48)
P
value
Intraoperative data
CPB time (min) 65  17 112  32 <.0001
Aortic crossclamp
time (min)
38  8 88  19 <.0001
Grafts per patient 2.9  0.5 2.7  0.6 .71
LITA graft 52 (96%) 47 (98%) .82
Use of catecholamines* 7 (13%) 8 (16.5%) .56
IABP support 1 (1.8%) 2 (4%) .12
Grafts flow (mL/min)
LITA to IVA 38  12 36  18 .68
SVG to MO 45  16 44  15 .79
SVG to IVP 48  11 50  19 .71
Early outcomes
Bleeding 2 (3.7%) 1 (2%) .15
Renal failure (dialysis) 2 (3.7%) 2 (4%) .81
LCOS 1 (1.8%) 1 (2%) .85
CVA 1 (1.8%) 0 –
Pneumonia 0 1 (2%) –
In-hospital mortality 1 (1.8%) 2 (4%) .12
Mechanical ventilation (h) 21  6 23  14 .68
ICU stay (d) 2.5  1.1 3.0  1.8 .06
Hospital stay (d) 9.3  2.8 9.7  5.1 .83
Data are presented as means  standard deviation or number (percentage), as shown.
CABG, Coronary artery bypass grafting;MVR, mitral valve repair; CPB, cardiopulmo-
nary bypass; LITA, left internal thoracic artery; IABP, intra-aortic balloon pump; IVA,
interventricular anterior artery; SVG, saphenous vein graft; MO, obtuse marginal ra-
mus; IVP, interventricular posterior ramus; LCOS, low cardiac output syndrome;
CVA, cardiovascular accident; ICU, intensive care unit. *Dopamine or dobutamine
greater than 5 mg $ kg1 $min1, adrenaline greater than 0.08 mg $ kg1 $min1, or both.rgery c August 2009
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RESULTS
No statistically significant difference was found between
the 2 groups according to preoperative demographics and
clinical and echocardiographic characteristics. No statistical
difference was found between the 2 groups in term of intra-
operative data, except for CPB time (P< .0001) and aortic
crossclamp time (P< .0001). Data are listed in Tables 1
and 2.
Early Mortality and Outcome
The overall in-hospital (<30 days) mortality rate for the
entire population was 3% (3 patients). One (1.8%) patient
died in the CABG group, and 2 (4%) patients died in the
CABG plus MVR group. Causes of in-hospital death were
low cardiac output in 2 patients and multiorgan failure in 1
patient.
Late Mortality and Outcome
Follow-up was completed in all survivors, with a mean
duration of 32  18 months. Late death occurred in 5
(9.5%) patients in the CABG group and in 1 (2%) patient
in the CABG plus MVR group. The cumulative survival
rate for both groups, including in-hospital mortality, is
shown in Figure 1; no statistically significant difference
was found between the 2 groups. Survival rates  standard
error for patients in the CABG group were 98.1%  2%,
92.6% 2.8%, and 88.8% 3.2% at 1, 3, and 5 years, re-
spectively. Survival rates standard error for patients in the
CABG plus MVR group were 95.8%  2.3% at 1 year and
3 years and 93.7%  3.1% at 5 years.
In the CABG group causes of late death were heart failure
in 3 patients (among whom 1 patient died during reoperation
on the mitral valve for severe MR with progressive left ven-
tricular dilatation after readmission for congestive heart fail-
ure), arrhythmia in 1 patient, and sudden death in 1 patient.
In the CABG plus MVR group sudden late death occurred in
1 patient with an LVEF of less than 35% and an LVEDD of
68 mm.
Effect on Postoperative MR and NYHA Class
Patients in the CABG plus MVR group had no late recur-
rent MR of greater than grade 1þ. Among the 4 (8.3%) pa-
tients with trivial postoperative residual MR, 1 died 33
months after the operation, and in the other 3 patients, the
MR grade remained stable during follow-up. In the CABG
group 40 (75.5%) patients had moderate postoperative
MR, and 13 (24.5%) patients had mild MR at hospital dis-
charge and at the first month’s control visit. At the last fol-
low-up, trivial MR was present in 2 (4%) patients, mild
MR was present in 17 (36%) patients, moderate MR was
present in 12 (25%) patients, and moderate-to-severe MR
was present in 17 (35%) patients. These data suggest thatThe Journal of Thoracic andCABG alone left 25% of patients in moderate MR, and in
35% of patients, the grade of MR worsened, from moderate
to moderate-to-severe. The time-related evolution of postop-
erative residual MR during follow-up is shown in Figure 2.
In the CABG group NYHA class improved from 2.2 
1.5 to 1.6 0.6 (P¼ .02), but in the CABG plusMVR group
it improved from 2.3 1.1 to 0.6 0.8 (P<.0001, Table 3).
At the last follow-up, NYHA class II or greater was present
in 21 (43.7%) patients in the CABG group and in 7 (15.5%)
patients in the CABG plus MVR group (P ¼ 0.002).
FIGURE 1. Cumulative survival curves for both groups. CABG, Coronary
artery bypass grafting; MVR, mitral valve repair.
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FIGURE 2. Residual postoperative mitral regurgitation (MR) in the coro-
nary artery bypass grafting group during follow-up.Cardiovascular Surgery c Volume 138, Number 2 281
Point/Counterpoint Fattouch et alTABLE 3. Clinical and echocardiographic follow-up data in all survivors
CABG group (n ¼ 48) CABGþMVR group (n ¼ 45)
Baseline Follow-up P value Baseline Follow-up P value
LVEDD (mm) 58  7 56  8 NS 59  8 52  7* <.001
LVESD (mm) 44  7 42  8 NS 45  8 37  5* <.001
LVEF (%) 43  9 45  7 NS 42  10 48  8 <.001
sPAP (mm Hg) 42  11 38  12 NS 40  10 26  5y <.0001
Left atrial size (mm) 38  7 44  8 <.001 39  8 36  3* NS
Tenting area (cm2) 1.7  0.7 1.8  0.3 NS 1.8  0.6 1.1  0.3* <.001
Mean NYHA class 2.2  1.5 1.6  0.6 .002 2.3  1.1 0.6  0.8y <.0001
Mean MR grade 2 1.7  0.6 NS 2 0.08  0.2y <.0001
Data are presented as means  standard deviation or number (%), as shown. CABG, Coronary artery bypass grafting; MVR, mitral valve repair; LVEDD, left ventricular end-di-
astolic dimension; LVESD, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; sPAP, systolic pulmonary artery pressure; NYHA, New York Heart
Association functional class; MR, mitral regurgitation. *P< .01 versus the CABG group. yP< .0001 versus the CABG group.Echocardiographic Results
Follow-up TTE analysis was performed in all survivors in
both groups. MR grade was improved in all patients (100%)
in the CABG plus MVR group compared with 19 (40%)
patients in the CABG group (P< .0001). Reversal in left
ventricular remodeling measured by change in LVEDD
(P< .001), LVESD (P< .001), and LVEF (P< .001) was
significantly observed in the CABG plus MVR group with
respect to baseline values, but no statistically significant dif-
ference in left ventricular reversal remodeling was observed
in the CABG group. Moreover, LVEDD (P < .01) and
LVESD (P< .01) were more decreased in the CABG plus
MVR group versus that seen in the CABG group. In the
CABG plus MVR group we found an improvement in
systolic PAP at follow-up with respect to patients in the
CABG group (P < .0001) and to baseline values (P <
.0001). The left atrial size changed from 39  8 to 37  3
mm in the CABG plus MVR group and from 38  6 to 44
 8 mm (P< .001) in the CABG group. The tenting area
at follow-up decreased significantly in patients in the
CABG plus MVR group with respect to the CABG group
(P< .0001) and baseline values (P< .001). Data are pre-
sented in Table 3.
TTE analysis during exercise was performed in all pa-
tients in the CABG plus MVR group and in 31 (65%) pa-
tients in the CABG group, excluding those with residual
moderate-to-severe MR (17 patients). We analyzed the clin-
ical status of patients during a treadmill test (based on onset
of symptoms, such as dyspnea, fatigue, and angina), the
modification of the grade of MR, and the worsening of
PAP. Data from the echocardiographic analysis during exer-
cise condition are shown in Figure 3. Among the 17 patients
with mild MR at rest, 10 (60%) showed a stable MR grade
during exercise, but in 7 (40%) patients the MR grade
changed from mild to moderate, with worsening in systolic
PAP and without symptom appearance. Among the 12 pa-
tients with moderate MR at rest, only 3 (25%) remained
with the same MR grade without symptoms, but in the other
9 (75%) patients, the MR grade changed from moderate to282 The Journal of Thoracic and Cardiovascular Sumoderate-to-severe, and the exercise test was stopped be-
cause of the appearance of dyspnea. No patient had chest
pain, significant ischemic electrocardiographic changes, or
arrhythmia. In the CABG plus MVR group 3 patients
stopped the exercise test for fatigue, and 42 patients com-
plete the exercise test without the appearance of dyspnea
or modification of MR grade.
DISCUSSION
The effect on early and long-term outcome of moderate
cIMR in patients presenting for CABG is controversial.
Clinical studies provide only limited information about the
dilemma to treat or not to treat moderate cIMR.10-20,24
This conflicting decision is mainly affected by the lack of
prospective studies and by the comparison of outcome in
dissimilar patient groups.10-13 In this randomized study we
aimed to evaluate the effect of mitral valve annuloplasty in
patients undergoing CABG with moderate cIMR and its ef-
fect on outcomes in terms of mortality, postoperative NYHA
functional class, and left ventricular remodeling compared
with CABG alone.
Authors favoring a conservative approach believe that
CABG alone can be sufficient to obtain a reduction in MR
postoperatively and to improve clinical symptoms. These
authors suggest that myocardial revascularization alone, re-
storing a good myocardial perfusion, leads to an enhance-
ment of left ventricular segmental and global kinesia, to
a reduction in left ventricular dimensions, and finally to a sig-
nificant reduction in MR because of restored valvular func-
tion. We believe that these findings are partially true because
in many patients with scarce area of myocardium after in-
farction, CABG could not be effective in myocardial func-
tional improvement, left ventricular remodeling can be
maintained, and postoperative reversal remodeling is not
predictable.
Duarte and colleagues13 showed that the late survival of
patients with coronary artery disease and preoperative
IMR undergoing CABG alone was similar to that of
a matched control group of patients with only coronaryrgery c August 2009
Fattouch et al Point/CounterpointFIGURE 3. Changes in mitral regurgitation (MR) grade during stress testing.CABG, Coronary artery bypass grafting;MVR, mitral valve repair; Pts, patients.artery disease undergoing CABG. Although no postopera-
tive determination of residual MR was performed in the
Duarte and colleagues study, the equivalent operative mor-
tality and long-term survival rates (mean follow-up, 4.3
years) led them to conclude that moderate IMR at the time
of revascularization does not always warrant operative cor-
rection.
Tolis and associates15 showed that isolated CABG was
sufficient to treat mild-to-moderate IMR and advanced
ischemic cardiomyopathy. They observed an improvement
in ejection fraction (mean from 22% to 31.5%) and
NYHA class, a good effect on MR (often disappeared),
and a good long-term survival (88% at 1 year, 65% at 3
years, and 50% at 5 years). Kim and coworkers16 showed
that combined MVR and CABG lead to similar 5-year sur-
vivals when compared with CABG alone (44%  5% vs
52%  5%).
On the other hand, Lam and colleagues17 from the Cleve-
land Clinic found that moderate IMR was not treated with
CABG alone and was associated with reduced survival in
patients with moderate IMR compared with patients under-
going matched bypass without moderate IMR (5-year sur-
vival, 73% vs 85%, P ¼ .003).
Our data do not demonstrate a positive effect on early and
late survival of adding valve repair to CABG with respect to
CABG alone, which is in accordance with previous stud-
ies.13-16,18 However, this study was not powered to detect
differences in survival.
Despite the fact that adding valve repair to CABG did not
increase survival, its efficacy in the improvement of postop-
erative NYHA class and on reversal of LV remodeling was
well demonstrated. Functional NYHA class changed from
2.2  1.5 to 1.6  0.6 (P ¼ .002) and from 2.3  1.1 to
0.6  0.8 (P < .0001) in the CABG and CABG plusThe Journal of Thoracic and CMVR groups, respectively. These data suggest that CABG
alone was less effective in improving NHYA class in pa-
tients with ischemic heart disease and concomitant moderate
cIMR with respect to CABG plus MVR (P< .0001, Fig-
ure 3). Our results are in contrast with results reported by
Kim and coworkers,16 who observed a similar improvement
in NYHA class at 2-year follow-up in their revascularization
(from 3.12 1 to 1.12 0.38) and repair (from 3.22 0.82
to 1.29  0.63) groups.
Moreover, we found that patients undergoing MVR had
improved LVEDD (P< .001), LVESD (P ¼ .001), and
LVEF (P < .001) with respect to baseline values, and
LVEDD (P< .01) and LVESD (P< .01) were significantly
decreased with respect to values in the CABG group. Our
data are in agreement with the work of Kim and coworkers16
and Kang and associates,18 who found reversed left ventric-
ular remodeling in patients who underwent combined MVR
and CABG. However, it is not clear whether improvements
in ischemic MR caused by MVR can have favorable effects
on left ventricular remodeling.We suggest that addingMVR
to CABG can abolish the regurgitant volume through the mi-
tral valve and preserve the left ventricle from volume over-
loading, which can contribute to long-term left ventricular
remodeling, despite the efficacy of myocardial revasculari-
zation.
Left ventricular reverse remodeling has been previously
observed after restrictive mitral annuloplasty.21 Some au-
thors suggested that in patients with IMR undergoing
CABG alone, the severity of MR and left ventricular func-
tion can improve because revascularization might lead to
left ventricular functional recovery with restoration of valve
coaptation.15 In other series of patients without postopera-
tive left ventricular functional recovery, MVR reduced the
grade of MR more significantly than CABG alone becauseardiovascular Surgery c Volume 138, Number 2 283
Point/Counterpoint Fattouch et alof a reduction in mitral annulus area caused by ring annulo-
plasty and improvement in the leaflet coaptation surface in-
dependently of left ventricular functional recovery.18-21
Because postoperative improvement of left ventricular func-
tion with revascularization alone cannot be predicted reli-
ably and the reversal of left ventricular remodeling was
widely observed after restrictive mitral annuloplasty, we
suggest use of the combination of CABG and MVR to treat
cIMR.
Our results are consistent with the work of Lam and col-
leagues,17 who found that moderate cIMR was not treated
properly with CABG alone and is associated with reduced
survival, and with the work of Aklog and coworkers,11
who observed that CABG alone left many patients with re-
sidual postoperative MR whereas mitral valve restrictive an-
nuloplasty resulted in the ideal approach, at least for patients
with annular dilatation.
The effect of postoperative cIMR on systolic PAP and on
left atrial size is still unclear, and few have investigated this
issue. In our series systolic PAP decreased from 42  11 to
38 12 mm Hg in the CABG group and from 40 10 to 26
 5 mm Hg (P<.0001) in the CABG plus MVR group (Ta-
ble 3). At follow-up, left atrial size decreased significantly in
the CABG plus MVR group versus that seen in the CABG
group (P< .01). Left atrial size remained nearly unchanged
compared with baseline values in patients who hadMVR but
increased in patients undergoing CABG alone (from 38  7
mm to 44  8 mm, P< .001). This could be related to the
fact that in the CABG group the grade of MR was worsened
during follow-up in 35% of patients and was still unchanged
in 25% of patients. Moreover, we observed that the left atrial
size was also increased in patients with postoperative trivial-
to-mild MR, probably because of the dynamic nature of
IMR, which could change in severity under different loading
condition.
Today it is evident from several studies5,6,11,19 that cIMR
is related to an adverse prognosis, and the high mortality rate
observed in such patients is related not only to its presence
but also more importantly to the grade of MR. However,
the evaluation of cIMR only under resting conditions might
underestimate the full effect of the lesion and its clinical ef-
fects. Indeed, cIMR is a dynamic lesion, and its severity can
vary over time. Lebrun and associates25 and Lancellotti and
colleagues26 showed that exercise-induced changes in regur-
gitant volume and in systolic pulmonary pressure were
larger in patients who stopped their exercise for dyspnea
compared with those who stopped for fatigue. A large exer-
cise-induced increase in cIMR, in particular an increase in
effective regurgitant orifice of 13 mm2 or greater, is associ-
ated with increased mortality and morbidity, hospital admis-
sion for worsening heart failure, and major cardiac events.
This observation suggests a need for a better understanding
of the dynamics of residual postoperative mild-to-moderate
MR and its effect on clinical outcome in patients who under-284 The Journal of Thoracic and Cardiovascular Suwent only CABG. Furthermore, in this subgroup of patients,
we performed an echocardiographic control during a bicycle
exercise test to evaluate changes in the grade ofMR, changes
in PAP, and symptoms.
During exercise, we showed that the 75% of patients with
moderate MR at rest had worse MR with congestive heart
failure symptoms, and 40% of patients with mild MR at
rest saw a change in MR grade from mild to moderate
with worsening in PAP without symptom appearance (Fig-
ure 3). Our results indicated that many patients who under-
went CABG alone with residual mild-to-moderate MR at
rest had more severe MR during different loading condi-
tions, which can contribute to symptom appearance and an
increase in systolic PAP and left atrial size. This could
lead to new onset of atrial fibrillation with poor long-term
prognosis. Furthermore, we believe that in these patients fu-
ture investigation must accurately address which patients
will have postoperative worsening in MR grade and conges-
tive heart failure symptoms despite the MR grade at rest.
CONCLUSIONS
Our primary end point was achieved, and the efficacy of
adding MVR to CABG is well demonstrated by the im-
provement of NYHA functional class and LVEF and by
the decrease in LVEDD and LVESD.
There was no effect on early and long-term survival if
MVR was added to CABG in patients with coronary artery
disease and moderate cIMR. However, our 32-month aver-
age follow-up is short, and the trends that are evident will
likely become more significant with time.
The combined approach was also found to be effective in
reducing systolic PAP and left atrial size with respect to
CABG alone, which left more patients with heart failure
symptoms. Moreover, the 35% of patients who underwent
CABG alone have worsened in MR grade at follow-up
(moved from grade 2þto 3þ), and the 75% (9 patients) of pa-
tients with stable moderate MR (grade 2þ) at rest move to
moderate-to-severe MR (grade 3þ) with appearance of dysp-
nea under exercise conditions.
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